121 related articles for article (PubMed ID: 10556676)
1. Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridine.
Maisonneuve IM; Glick SD
Eur J Pharmacol; 1999 Oct; 383(1):15-21. PubMed ID: 10556676
[TBL] [Abstract][Full Text] [Related]
2. 18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbens.
Taraschenko OD; Shulan JM; Maisonneuve IM; Glick SD
Synapse; 2007 Jul; 61(7):547-60. PubMed ID: 17447255
[TBL] [Abstract][Full Text] [Related]
3. The potential anti-addictive agent, 18-methoxycoronaridine, blocks the sensitized locomotor and dopamine responses produced by repeated morphine treatment.
Szumlinski KK; Maisonneuve IM; Glick SD
Brain Res; 2000 May; 864(1):13-23. PubMed ID: 10793182
[TBL] [Abstract][Full Text] [Related]
4. Prior morphine exposure enhances ibogaine antagonism of morphine-induced dopamine release in rats.
Pearl SM; Maisonneuve IM; Glick SD
Neuropharmacology; 1996; 35(12):1779-84. PubMed ID: 9076757
[TBL] [Abstract][Full Text] [Related]
5. 18-Methoxycoronardine attenuates nicotine-induced dopamine release and nicotine preferences in rats.
Glick SD; Maisonneuve IM; Visker KE; Fritz KA; Bandarage UK; Kuehne ME
Psychopharmacology (Berl); 1998 Oct; 139(3):274-80. PubMed ID: 9784085
[TBL] [Abstract][Full Text] [Related]
6. 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats.
Glick SD; Kuehne ME; Maisonneuve IM; Bandarage UK; Molinari HH
Brain Res; 1996 May; 719(1-2):29-35. PubMed ID: 8782860
[TBL] [Abstract][Full Text] [Related]
7. Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study.
Maisonneuve IM; Keller RW; Glick SD
Eur J Pharmacol; 1991 Jun; 199(1):35-42. PubMed ID: 1893925
[TBL] [Abstract][Full Text] [Related]
8. Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum.
Glick SD; Kuehne ME; Raucci J; Wilson TE; Larson D; Keller RW; Carlson JN
Brain Res; 1994 Sep; 657(1-2):14-22. PubMed ID: 7820611
[TBL] [Abstract][Full Text] [Related]
9. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action.
Glick SD; Maisonneuve IM; Szumlinski KK
Ann N Y Acad Sci; 2000 Sep; 914():369-86. PubMed ID: 11085336
[TBL] [Abstract][Full Text] [Related]
10. Development of novel medications for drug addiction. The legacy of an African shrub.
Glick SD; Maisonneuve IM
Ann N Y Acad Sci; 2000; 909():88-103. PubMed ID: 10911925
[TBL] [Abstract][Full Text] [Related]
11. Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: a microdialysis study in rats.
Di Giannuario A; Pieretti S; Catalani A; Loizzo A
Neurosci Lett; 1999 Sep; 272(3):183-6. PubMed ID: 10505611
[TBL] [Abstract][Full Text] [Related]
12. Effects of 18-methoxycoronaridine on ghrelin-induced increases in sucrose intake and accumbal dopamine overflow in female rats.
McCallum SE; Taraschenko OD; Hathaway ER; Vincent MY; Glick SD
Psychopharmacology (Berl); 2011 May; 215(2):247-56. PubMed ID: 21210086
[TBL] [Abstract][Full Text] [Related]
13. Implication of Rho-associated kinase in the elevation of extracellular dopamine levels and its related behaviors induced by methamphetamine in rats.
Narita M; Takagi M; Aoki K; Kuzumaki N; Suzuki T
J Neurochem; 2003 Jul; 86(2):273-82. PubMed ID: 12871568
[TBL] [Abstract][Full Text] [Related]
14. Effects of 18-methoxycoronaridine on acute signs of morphine withdrawal in rats.
Rho B; Glick SD
Neuroreport; 1998 May; 9(7):1283-5. PubMed ID: 9631413
[TBL] [Abstract][Full Text] [Related]
15. Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment.
Maisonneuve IM; Glick SD
Pharmacol Biochem Behav; 2003 Jun; 75(3):607-18. PubMed ID: 12895678
[TBL] [Abstract][Full Text] [Related]
16. Interactions between 18-methoxycoronaridine (18-MC) and cocaine: dissociation of behavioural and neurochemical sensitization.
Szumlinski KK; McCafferty CA; Maisonneuve IM; Glick SD
Brain Res; 2000 Jul; 871(2):245-58. PubMed ID: 10899291
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration.
Glick SD; Maisonneuve IM; Kitchen BA; Fleck MW
Eur J Pharmacol; 2002 Mar; 438(1-2):99-105. PubMed ID: 11906717
[TBL] [Abstract][Full Text] [Related]
18. Acute iboga alkaloid effects on extracellular serotonin (5-HT) levels in nucleus accumbens and striatum in rats.
Wei D; Maisonneuve IM; Kuehne ME; Glick SD
Brain Res; 1998 Aug; 800(2):260-8. PubMed ID: 9685673
[TBL] [Abstract][Full Text] [Related]
19. 18-Methoxycoronaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in rats.
Glick SD; Ramirez RL; Livi JM; Maisonneuve IM
Eur J Pharmacol; 2006 May; 537(1-3):94-8. PubMed ID: 16626688
[TBL] [Abstract][Full Text] [Related]
20. α3β4 nicotinic acetylcholine receptors in the medial habenula modulate the mesolimbic dopaminergic response to acute nicotine in vivo.
McCallum SE; Cowe MA; Lewis SW; Glick SD
Neuropharmacology; 2012 Sep; 63(3):434-40. PubMed ID: 22561751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
